SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-13-000002
Filing Date
2013-11-12
Accepted
2013-11-12 08:05:41
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prx-20130930x10q.htm 10-Q 2794926
2 CEO CERTIFICATION prx-20130930xex311.htm EX-31.1 13439
3 CFO CERTIFICATION prx-20130930xex312.htm EX-31.2 13309
4 CEO CERTIFICATION ATTACHED prx-20130930xex321.htm EX-32.1 5844
5 CFO CERTIFICATION ATTACHED prx-20130930xex322.htm EX-32.2 5381
  Complete submission text file 0000878088-13-000002.txt   17510513

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prx-20130930.xml EX-101.INS 3407195
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prx-20130930.xsd EX-101.SCH 82359
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prx-20130930_cal.xml EX-101.CAL 106308
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prx-20130930_def.xml EX-101.DEF 529256
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prx-20130930_lab.xml EX-101.LAB 934292
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prx-20130930_pre.xml EX-101.PRE 642352
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 131207059
SIC: 2834 Pharmaceutical Preparations